Iosat 130 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FSYYH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,613
Award facts
- Contract value 100% obligated
- $1,612.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for IOSAT 130 mg tablets (14-count packaging). This firm fixed-price delivery order, valued at $1,612.80, was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The order carries no set-aside designation and represents a purchase of potassium iodide tablets, which are used for thyroid protection in radiological emergency scenarios. This award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a robust portfolio of delivery orders from the Defense Logistics Agency covering diverse medical products ranging from prescription medications to biologics and specialty pharmaceuticals. The company's consistent success in competing for federal contracts without set-aside designations reflects its competitive positioning as a woman-owned small business in the pharmaceutical wholesaler market. Its registration in SAM.gov since 2001 and focus on providing direct distribution of pharmaceutical products to Department of Defense healthcare sites underscore its operational capability to fulfill federal government medical supply requirements efficiently and reliably.
Quick answers
Who was awarded contract SPE2DB25FSYYH?
SPE2DB25FSYYH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FSYYH worth?
The government has obligated $1,613 on SPE2DB25FSYYH.
Is contract SPE2DB25FSYYH an order under another contract?
Yes. SPE2DB25FSYYH is a delivery order under SPE2DB25D9349, an indefinite delivery contract.
Was contract SPE2DB25FSYYH competed?
The extent of competition for SPE2DB25FSYYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award